VI Technology blood products Pages on BioPortfolio:

BioPortfolio - V.I. Technologies Incorporated
V.I. Technologies is a leading developer of a broadportfolio of blood products and systems which use its proprietary pathogen inactivation technologies. ...
http://www.bioportfolio.com/biocorporate/10719-V.I._Technolo...

BioPortfolio - V.I. Technologies watertown Massachusetts 02472 U.S.A.
V.I. Technologies, Inc., Watertown, Massachusetts 02472, USA. BACKGROUND: The outbreak of West Nile virus (WNV) is the most recent reminder that the blood .
...
http://www.bioportfolio.com/search/V.I._Technologies_waterto...

BioPortfolio - val tech diagnostics
V.I. Technologies is a leading developer of a broadportfolio of blood products and systems ... Val Tech Diagnostics ... www.ahdiag.dk/ View full profile . ...
http://www.bioportfolio.com/search/val_tech_diagnostics.html...

BioPortfolio - VI technology usa
BioPortfolio - V.I. Technologies Incorporated ... of blood products and systems which .... USA Voicemail and Fax: (+1) 415 680 2472. All rights reserved. ...
http://www.bioportfolio.com/search/VI_technology_usa.html...

BioPortfolio - what is HBV called that the pathogen produces
BioPortfolio - V.I. Technologies Incorporated ... of blood products and systems which use its proprietary pathogen ... hepatitis B virus ("HBV"), ...
http://www.bioportfolio.com/search/what_is_HBV_called_that_t...

BioPortfolio - V.I. Technologies Incorporated
View full profile · V.I. Technologies Incorporated. V.I. Technologies is a leading developer of a broadportfolio of blood products . ...
http://www.bioportfolio.com/search/V.I._Technologies_Incorpo...

HR Resourcing Excellence Series
Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies Markets, Companies and Opportunities. 6. Picture Archiving and Communications
...
http://www.bioportfolio.com/cgi-bin/acatalog/HR_Resourcing_E...

Cellexus Biosystems appoints Rob Molloy and Bob Cumming as non ...
Three products will be developed all based around the core technology - the ... appoints Robert Molloy and Robert Cumming as non- executive Directors /6 ...
http://www.bioportfolio.com/biotech_news/Cellexus_Biosystems...

Innovations in Cardiovascular Disease Management Latest surgical ...
Development Stage Products and Current Status 55 Future Technologies and Trends 58 ... Chapter 6 New and Emerging Cardiovascular Drugs 128 Summary 128 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_815.html...

Next-Generation Nutraceuticals Food and pharma convergence in ...
vi Alliances 129 Food-pharma alliances 129 Alliances with new technology ... Table 5.24: Some functional food and drink products launched by pharma ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_659.html...

Results from other life science and pharmaceutical sites:

American Society of Hematology - 42nd Annual Meeting Pathogen ...
the rationale for pathogen-inactivation of blood products. and various approaches to their .... presented by J Chapman (VI Technologies Inc, Watertown,
...
http://www.biomedcentral.com/content/pdf/cd-398336.pdf...

ENFORCEMENT REPORT FOR DECEMBER 11, 2002
Manufacturer: V.I. Technologies, Melville, NY. Firm initiated recall is ongoing. REASON Blood products, containing fibrin like material, were distributed. ...
http://www.fda.gov/bbs/topics/enforce/2002/ENF00773.html...

Trypanosoma cruzi Inactivation in Human Platelet Concentrates and ...
Transmission of T. cruzi from blood products is a frequent occurrence in ..... and an ethylene amine derivative (V.I. Technologies, Inc., Watertown, Mass. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=15...

FDA Enforcement Report
REASON Blood products tested negative for the antibody to the hepatitis C virus .... MANUFACTURER V.I. Technologies, Inc. (VITEX), also konwn as Melville ...
http://www.fda.gov/bbs/topics/ENFORCE/ENF00486.html...

Audubon biotech firms
That's what V.I. Technologies stands for. VITEX was founded in 1995 as a ... Blood safety is of special concern here, since such products would be derived
...
http://www.columbia.edu/cu/21stC/issue-3.1/coxeter.html...

Recommendations and Licensure Requirements for Leukocyte-Reduced ...
Recent advances in leukocyte reduction technology have contributed to the ease and effectiveness of. removing leukocytes from blood and blood products ...
http://www.fda.gov/Cber/bldmem/mem52996.pdf...

Inactivation of pathogens in blood and blood produ...[Med Health R ...
Inactivation of pathogens in blood and blood products. Ben-Hur E. VITEX (V.I. Technologies, Inc.), New York, NY 10032, USA. ehud.ben-hur@vitechnologies.com
...
http://www.ncbi.nlm.nih.gov/pubmed/9884539...

FDA Updates--September-October 1998 FDA Consumer
... that result in an effective, safe blood product. SD plasma is manufactured by V.I. Technologies Inc., Melville, N.Y., under the trade name VIPLAS/SD. ...
http://www.fda.gov/FDAC/departs/1998/598_upd.html...

High-Sensitivity PCR Detection of Parvovirus B19 in Plasma
Consequently, B19 contamination of pooled blood products is of major significance, ... were obtained from Aristides Lazo (VI Technologies, Boston,
Mass. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=13...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.